ISOThrive has exclusively licensed two U.S. and one Canadian patents from Louisiana State University:

“Isomaltooligosaccharides from Leuconostoc as neutraceuticals”
U.S. Patent No. 7,291,607, issued November 6, 2007.  View Patent »
“Isomaltooligosaccharides from Leuconostoc as neutraceuticals”
Canadian Patent No. 2,467,695, issued March 16, 2010.  View Patent »
“Isomaltooligosaccharides to inhibit avian pathogenic intestinal bacteria”
U.S. Patent No. 7,772,212, issued August 10, 2010.   View Patent »

ISOThrive has several U.S. patents pending and one patent pending worldwide.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.